Yoshiaki Omura
ScientificTracks: J Cancer Sci Ther
Through clinical research, 10 optimal doses of important factors that inhibit existing malignant melanoma and other cancers have been found. This includes: 1) Increasing normal cell telomere to an optimally high value by various methods, 2) Ethyl Alcohol of even 12~20% can inhibit cancer activity for several hours, 3) Optimal dosage of about 400 I.U. vitamin D 3 , 4) Nori, 5) Certain cheeses, etc. 14 important factors enhancing malignant melanoma and other cancers include: 1) 70% Isopropyl Alcohol, 2) Eating fish skin, 3) Eating burned food, 4) Vitamin D3 of 800 I.U. or higher, 5) One or more cloves of Garlic, particularly in the presence of a high dosage of vitamin D 3 , 6) Asbestos-containing food or water, 7) Electro-magnetic field from cellular phones, computers, and microwaves, 8) Many female cosmetic products applied to face or lip, 9) Wearing BDORT strong negative clothes or accessories, etc. Using the above practical information, many types of cancers can be treated safely with minimum side effects. Concerning the optimal dosage of vitamin D 3 , some doctors are giving over 800 I.U. vitamin D 3 , with many physicians giving 2000 I.U., which can increase cancer activities significantly. However, when given 400 I.U. of vitamin D 3 to most adult patients, most cancer activities will be significantly reduced without any side effects. These effects can be evaluated by non-invasively measuring the amount telomere, integrin α 5 β 1 , and oncogene C-fosAb2, both of which always increase in the presence of a malignancy, and 8-OH-dG, which increases in the presence of DNA mutation.
Yoshiaki Omura received both Oncology Residency Training and a Doctor of Science degree through research on pharmaco-electro physiology of single cells in vivo and in vitro from Columbia University. He has published over 250 articles and 7 books. He is currently editor-in-chief of Acupuncture & Electro-Therapeutics Research, International Journal of Integrated Medicine, and Executive Editor of Integrative Oncology. Using his new diagnostic method, which received U.S. patent, he can non-invasively and rapidly measure many neurotransmitters, chemicals, asbestos, viruses, and bacteria. He developed a non-invasive, quick diagnostic method of malignancies, as well as a method of evaluating the effects of any treatment
Cancer Science & Therapy received 5332 citations as per Google Scholar report